Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982;22(1):7-14.
doi: 10.1007/BF00606418.

Prazosin depression of baroreflex function in hypertensive man

Clinical Trial

Prazosin depression of baroreflex function in hypertensive man

E H Sasso et al. Eur J Clin Pharmacol. 1982.

Abstract

Prazosin is a post synaptic alpha adrenergic blocker effective in hypertension, whose hypotensive effect is unaccompanied by reflex tachycardia or hyperreninemia, nor by other evidence of increased sympathetic activity. We studied the baroreceptor reflex arc as a potential mediator of these effects. Twenty-two essential hypertensive men were treated with prazosin alone versus placebo, and experienced a blood pressure fall (from 114.8 +/- 3.6 down to 101.1 +/- 2.5 mmHg, p less than 0.005) unaccompanied by any change in heart rate, plasma renin activity, or several other indices of sympathetic nervous system activity (plasma dopamine-beta-hydroxylase activity; urinary excretion of free catecholamines and vanillyl mandelic acid; all p less than 0.1). Concomitant with the blood pressure fall, there was a significant depression of baroreflex arc sensitivity, from 11.4 +/- 2.0 ms/mmHg down to 6.6 +/- 1.9 ms/mmHg (p less than 0.05), without an associated change in cardiac vagal inhibition (291.2 +/- 46.2 versus 300.3 +/- 19.2 ms, p greater than 0.1). Baroreflex arc sensitivity depression may in part explain the lack of reflex sympathetic outflow noted during prazosin treatment of hypertension.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Physiol. 1974 Aug;227(2):295-9 - PubMed
    1. Med J Aust. 1977 Aug 27;2(2 Suppl):30-2 - PubMed
    1. J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55 - PubMed
    1. J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S1-7 - PubMed
    1. Br Med J. 1976 Nov 27;2(6047):1293-4 - PubMed

Publication types

LinkOut - more resources